Affordable Access

Access to the full text

Infrared-emitting, peptidase-resistant fluorescent ligands of the bradykinin B2 receptor: application to cytofluorometry and imaging

  • Gera, Lajos1
  • Charest-Morin, Xavier2
  • Jean, Melissa3
  • Bachelard, Hélène3
  • Marceau, François4
  • 1 University of Colorado Denver, Department of Biochemistry, Aurora, CO, 80045, USA , Aurora (United States)
  • 2 Centre de recherche, CHU de Québec Université Laval, Axe maladies infectieuses et immunitaires, Quebec, QC, G1V 4G2, Canada , Quebec (Canada)
  • 3 Centre de recherche, CHU de Québec Université Laval, Axe endocrinologie et néphrologie, Quebec, QC, G1V 4G2, Canada , Quebec (Canada)
  • 4 Centre de Recherche du CHU de Québec (CHUL), Room T1-49, 2705 Boulevard Laurier, Quebec City, QC, G1V 4G2, Canada , Quebec City (Canada)
Published Article
BMC Research Notes
Springer (Biomed Central Ltd.)
Publication Date
Sep 26, 2016
DOI: 10.1186/s13104-016-2258-1
Springer Nature


BackgroundWe have previously reported the design, pharmacological properties and imaging application of bradykinin (BK) B2 receptor (B2R) ligands conjugated with fluorophores such as fluorescein derivatives at their N-terminus. To take advantage of the high penetration of infrared light into living tissues and their low autofluorescence in this region of the spectrum, additional probes conjugated with cyanine dye 7 (Cy7) were synthesized and characterized.ResultsThe antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-BK) and the agonist B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-BK) were N-terminally extended with the infrared fluorophore Cy7, producing the peptides B-10665 and B-10666, respectively. Pharmacological studies indicated that the agonist B-10666 lost much affinity for the B2R vs. the parent peptide, whereas the antagonist B-10665 better retained its potency vs. B-9430 (competition of [3H]BK binding to human B2R, contractility of the human isolated umbilical vein for which potency losses were more important in each case). Both probes stained HEK 293 cells that expressed the B2R-green fluorescent protein (GFP) construction in a specific manner (confocal microscopy) and with very extensive co-localization of the green and infrared fluorescence in either case. The agonist B-10666 at 100 nM promoted the endocytosis of B2R-GFP in live cells, but not the antagonist version at 10–25 nM. The Cy7-labeled peptides did not label cells expressing the β2-adrenoceptor-GFP construction. B-10665 at low nanomolar concentrations was an effective probe for the recombinant B2Rs in cytofluorometry and macroscopic imaging of cell wells (IVIS imaging system operated for infrared fluorescence detection).ConclusionsDespite a propensity for non-specific binding when used at high concentrations and limited sensitivity, Cy7-conjugated peptidase-resistant B2R ligands support original imaging and cytofluorometric applications.

Report this publication


Seen <100 times